AI assistant
Sending…
Gossamer Bio, Inc. — Director's Dealing 2021
Jun 14, 2021
32603_dirs_2021-06-14_d69be11d-f39e-4dc3-875c-ee1e4803fba5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Gossamer Bio, Inc. (GOSS)
CIK: 0001728117
Period of Report: 2021-06-10
Reporting Person: Milligan Sandra (Director)
More from Gossamer Bio, Inc.
Proxy Solicitation & Information Statement
2026
May 18
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 24
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20